Company: Aspen Aerogels
Aspen Aerogels, Inc. (“Aspen Aerogels”) (NYSE: ASPN) announced today that it has priced its initial public offering of 7,500,000 shares of common stock at $11.00 per share for total gross proceeds of $82,500,000. In addition, Aspen Aerogels has granted the underwriters a 30-day option to purchase up to an additional 1,125,000 shares of common stock at the initial public offering price less the underwriting discount. Aspen Aerogels’ shares are expected to begin trading on the New York Stock Exchange on June 13, 2014, under the symbol “ASPN.”
Aspen Aerogels intends to use the net proceeds from this offering to fund additional expenditure for its third production line at its facility in East Providence, R.I., for repayment of amounts outstanding under its revolving line of credit and subordinated notes, and for general corporate purposes, which will include funding a portion of the design, development and construction of its planned second production plant in Europe or Asia after completion of its third production line at its facility in East Providence, R.I.
Barclays, J.P. Morgan, and Citigroup are acting as joint book-running managers of the offering. Baird and Canaccord Genuity are acting as co-managers of the offering.
The offering is being made only by means of a prospectus. Copies of the prospectus related to the offering may be obtained from Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, or by email at: firstname.lastname@example.org, or by telephone: (888) 603-5847; J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717 or by calling tolling-free at 1-866-803-9204; and Citigroup Global Markets Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717 (Tel: 800-831-9146).
This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. A registration statement relating to these securities has been filed and, on June 12, 2014, was declared effective by the Securities and Exchange Commission.
About Aspen Aerogels, Inc.
Aspen Aerogels is an energy technology company that designs, develops and manufactures innovative, high-performance aerogel insulation used primarily in large-scale energy infrastructure facilities. Headquartered in Northborough, Mass., Aspen Aerogels manufactures its Cryogel®, Pyrogel® and Spaceloft® products at its facility in East Providence, R.I.
Special Note Regarding Forward-Looking and Cautionary Statements
This press release contains forward-looking statements including statements relating to Aspen Aerogel’s initial public offering. These statements are not historical facts but rather are based on Aspen Aerogels’ current expectations, estimates and projections regarding Aspen Aerogels’ business, operations and other factors relating thereto, including with respect to the initial public offering. Words such as “may,” “will,” “could,” “would,” “should,” “anticipate,” “predict,” “potential,” “continue,” “expects,” “intends,” “plans,” “projects,” “believes,” “estimates” and similar expressions are used to identify these forward-looking statements. These statements are only predictions and as such are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described from time to time in Aspen Aerogels’ filings with the SEC.
SOURCE Aspen Aerogels, Inc.
Susan White, 508-691-1143, email@example.com